Dataset Information

MAC protocol with grouping awareness GMAC for large scale Internet-of-Things network.

ABSTRACT: The development of Medium Access Control (MAC) protocols for Internet of Things should consider various aspects such as energy saving, scalability for a wide number of nodes, and grouping awareness. Although numerous protocols consider these aspects in the limited view of handling the medium access, the proposed Grouping MAC (GMAC) exploits prior knowledge of geographic node distribution in the environment and their priority levels. Such awareness enables GMAC to significantly reduce the number of collisions and prolong the network lifetime. GMAC is developed on the basis of five cycles that manage data transmission between sensors and cluster head and between cluster head and sink. These two stages of communication increase the efficiency of energy consumption for transmitting packets. In addition, GMAC contains slot decomposition and assignment based on node priority, and, therefore, is a grouping-aware protocol. Compared with standard benchmarks IEEE 802.15.4 and industrial automation standard 100.11a and user-defined grouping, GMAC protocols generate a Packet Delivery Ratio (PDR) higher than 90%, whereas the PDR of benchmark is as low as 75% in some scenarios and 30% in others. In addition, the GMAC accomplishes lower end-to-end (e2e) delay than the least e2e delay of IEEE with a difference of 3 s. Regarding energy consumption, the consumed energy is 28.1 W/h for GMAC-IEEE Energy Aware (EA) and GMAC-IEEE, which is less than that for IEEE 802.15.4 (578 W/h) in certain scenarios.

SUBMITTER: Sameer Sadeq A

PROVIDER: S-EPMC8627235 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundDemographic changes and a low birth rate have led to a workforce shortage in Japan. To address this issue, the government has promoted engagement of female employment. However, increased female employment can impact women's health. Using Internet of Things (IoT) and apps to manage women's health has gained attention, but few studies have focused on working women.ObjectiveThis study aimed to clarify the current situation of working women and their use of IoT or apps to manage their health.MethodsA large-scale, nationwide internet survey was conducted among 10,000 female participants aged from 20 years to 64 years in Japan. Participants were recruited from a marketing research company's active survey panel of 5.24 million members. The survey included questions about health status, sociodemographic factors, psychological characteristics, and the use of IoT or apps for health management. We compared perceived health status and reasons for current IoT use using t tests and assessed participant characteristics that predicted IoT use using the C5.0 decision tree algorithm. Ethical approval was granted by St. Luke's International University.ResultsAmong participants, 14.6% (1455/10,000) currently used IoT or apps, 7% (695/10,000) used them previously, and 78.5% (7850/10,000) had never used them. Current users (42.7 years old) were older than past users (39.7 years old). Discrepancies were observed between participants' perceived health problems and the purpose for using IoT or apps, with 21.3% (2130/10,000) of all women reporting they experienced menstrual symptoms or disorders but only 3.5% (347/10,000) used IoT or apps to manage the same symptom. On the other hand, current users were more likely to use IoT or apps to manage nutrition-related problems such as underweight or obesity (405/1455, 27.8%). Device use was highest among current users, with 87.3% (1270/1455) using smartphones, 19.7% (287/1455) using smartwatches, and 13.3% (194/1455) using PCs. Decision tree analysis identified 6 clusters, the largest consisting of 81.6% (5323/6523) of non-IoT users who did not exercise regularly, while pregnant women were more likely to use IoT or apps.ConclusionsOur findings highlight the idea that woman with particular health problems (ie, menstrual symptoms or disorders and premenstrual syndrome) have lower use of IoT or apps, suggesting an unmet need for IoT and apps in specific areas.

Project description:BackgroundInternet of Things (IoT), or Industry 4.0, represents a smart shift to more interconnected manufacturing processes where individual entities within the supply chain communicate with each other to achieve greater flexibility and responsiveness in general manufacturing and leaner manufacturing to reduce the cost of production. IoT has become instrumental in driving leaner manufacturing and more efficient systems in other industries such as transportation and logistics. Cell-based therapeutic products could potentially transform various diseases; however, the delivery of these products is complex and challenging.ObjectiveThis study aims to understand the applicability of IoT in cell-based product supply chains and delivery.MethodsWe will search Medline, EMBASE (OvidSP), Web of Science, Cochrane Library & HEED, Scopus, ACM digital library, INSPEC, ScienceDirect, and the IEEE Xplore Digital Library for studies published after 2008 using a combination of keywords and subject headings related to IoT used in cell therapies. Additionally, a Google search to identify gray literature will be conducted. Two authors will independently screen the titles and abstracts identified from the search and accept or reject the studies according to the study inclusion criteria. Any discrepancies will then be discussed and resolved. The quality of the selected literature will be assessed using the Critical Appraisal Skills Programme systematic review checklist.ResultsData from eligible publications will be abstracted into a predesigned form to map the current and future directions of the technologies, applications, benefits, and challenges in the implementation of IoT in regenerative medicine. This study will be published in a peer-reviewed journal in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. This systematic review will be executed by June 2020, and the completed review will be published in a peer-reviewed journal to inform future developments in IoT application for the delivery of cell-based therapies.ConclusionsThis review paper will provide an overview of all technologies available in the area and inspect the current IoT applications in cell-based therapies to identify the benefits, challenges, and future directions of using IoT to allow safe and cost-effective delivery of cell-based therapies.International registered report identifier (irrid)PRR1-10.2196/16935.

Dataset Information

MAC protocol with grouping awareness GMAC for large scale Internet-of-Things network.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets